1-15 of 15
Scott Wadler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In vivo synergy between oncolytic reovirus and gemcitibane in ras-mutated human HCT116 xenografts

Maureen Lane, Jeanne Fahey, Christen Besanceney, Nancy Hamel, Bo Yu, Brad Thompson, Matt Coffey, Scott Wadler
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 4812.
Published: 01 May 2007
View article titled, <em>In vivo </em>synergy between oncolytic reovirus and gemcitibane in ras-mutated human HCT116 xenografts
Journal Articles

Pulmonary fine needle aspirates (FNA) with diverse radiographic appearances exhibit distinct patterns of gene expression

Maureen E. Lane, David F. Yankelevitz, Claudia I. Henschke, Madeline F. Vazquez, Zhaoying Zhang, Arin Kramer, Bo Yu, Scott Wadler
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 206.
Published: 01 May 2005
View article titled, Pulmonary fine needle aspirates (FNA) with diverse radiographic appearances exhibit distinct patterns of gene expression
Journal Articles

Genetic analysis of proteasome-related pathways in PS-341 resistant human colon cancer cell lines

Allyson J. Ocean, Maureen E. Lane, Xianchun Huang, Zhaoying Xiang, Bo Yu, Scott Wadler
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 142–143.
Published: 01 April 2004
View article titled, Genetic analysis of proteasome-related pathways in PS-341 resistant human colon cancer cell lines
Journal Articles

Patterns of gene expression in pulmonary fine needle aspirates (FNA) with diverse radiographic appearances

Maureen E. Lane, David F. Yankelevitz, Claudia I. Henschke, Madeline F. Vaquez, Zhaoying Xiang, Xianchun Huang, Arin L. Kramer, Allyson J. Ocean, Bo Yu, Scott Wadler
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1291.
Published: 01 April 2004
View article titled, Patterns of gene expression in pulmonary fine needle aspirates (FNA) with diverse radiographic appearances
Journal Articles

A Novel cdk2-selective Inhibitor, SU9516, Induces Apoptosis in Colon Carcinoma Cells

Maureen E. Lane, Bo Yu, Audie Rice, Kenneth E. Lipson, Chris Liang, Li Sun, Cho Tang, Gerald McMahon, Richard G. Pestell, Scott Wadler
Journal: Cancer Research
Cancer Res (2001) 61 (16): 6170–6177.
Published: 01 August 2001
View article titled, A Novel cdk2-selective Inhibitor, SU9516, Induces Apoptosis in Colon Carcinoma Cells
Open the PDF for A Novel cdk2-selective Inhibitor, SU9516, Induces Apoptosis in Colon Carcinoma Cells in another window
Journal Articles

c-myc/p53 Interaction Determines Sensitivity of Human Colon Carcinoma Cells to 5-Fluorouracil in Vitro and in Vivo

Diego Arango, Georgia A. Corner, Scott Wadler, Paul J. Catalano, Leonard H. Augenlicht
Journal: Cancer Research
Cancer Res (2001) 61 (12): 4910–4915.
Published: 01 June 2001
View article titled, c-myc/p53 Interaction Determines Sensitivity of Human Colon Carcinoma Cells to 5-Fluorouracil <em>in Vitro</em> and <em>in Vivo</em>
Open the PDF for c-myc/p53 Interaction Determines Sensitivity of Human Colon Carcinoma Cells to 5-Fluorouracil <em>in Vitro</em> and <em>in Vivo</em> in another window
Journal Articles

Low-Level c-myc Amplification in Human Colonic Carcinoma Cell Lines and Tumors: A Frequent, p53-independent Mutation Associated with Improved Outcome in a Randomized Multi-institutional Trial

Leonard H. Augenlicht, Scott Wadler, Georgia Corner, Christine Richards, Louise Ryan, Asha S. Multani, Sen Pathak, Al Benson, Daniel Haller, Barbara G. Heerdt
Journal: Cancer Research
Cancer Res (1997) 57 (9): 1769–1775.
Published: 01 May 1997
View article titled, Low-Level c-<em>myc</em> Amplification in Human Colonic Carcinoma Cell Lines and Tumors: A Frequent, p53-independent Mutation Associated with Improved Outcome in a Randomized Multi-institutional Trial
Open the PDF for Low-Level c-<em>myc</em> Amplification in Human Colonic Carcinoma Cell Lines and Tumors: A Frequent, p53-independent Mutation Associated with Improved Outcome in a Randomized Multi-institutional Trial in another window
Journal Articles

5-Ethoxy-2′-deoxyuridine, a Novel Substrate for Thymidine Phosphorylase, Potentiates the Antitumor Activity of 5-Fluorouracil When Used in Combination with Interferon, an Inducer of Thymidine Phosphorylase Expression

Edward L. Schwartz, Nicole Baptiste, Sreenivasalu Megati, Scott Wadler, Brian A. Otter
Journal: Cancer Research
Cancer Res (1995) 55 (16): 3543–3550.
Published: 01 August 1995
View article titled, 5-Ethoxy-2′-deoxyuridine, a Novel Substrate for Thymidine Phosphorylase, Potentiates the Antitumor Activity of 5-Fluorouracil When Used in Combination with Interferon, an Inducer of Thymidine Phosphorylase Expression
Open the PDF for 5-Ethoxy-2′-deoxyuridine, a Novel Substrate for Thymidine Phosphorylase, Potentiates the Antitumor Activity of 5-Fluorouracil When Used in Combination with Interferon, an Inducer of Thymidine Phosphorylase Expression in another window
Journal Articles

Potentiation of the Antitumor Activity of 5-Fluorouracil in Colon Carcinoma Cells by the Combination of Interferon and Deoxyribonucleosides Results from Complementary Effects on Thymidine Phosphorylase

Edward L. Schwartz, Nicole Baptiste, Carolyn J. O'Connor, Scott Wadler, Brian A. Otter
Journal: Cancer Research
Cancer Res (1994) 54 (6): 1472–1478.
Published: 01 March 1994
View article titled, Potentiation of the Antitumor Activity of 5-Fluorouracil in Colon Carcinoma Cells by the Combination of Interferon and Deoxyribonucleosides Results from Complementary Effects on Thymidine Phosphorylase
Open the PDF for Potentiation of the Antitumor Activity of 5-Fluorouracil in Colon Carcinoma Cells by the Combination of Interferon and Deoxyribonucleosides Results from Complementary Effects on Thymidine Phosphorylase in another window
Journal Articles

Phase I Trial of Cyclophosphamide, Doxorubicin, and 5-Fluorouracil plus Interferon-α2b in Patients with Advanced Breast Cancer

Joseph A. Sparano, Scott Wadler, Leonard Liebes, Nicholas J. Robert, Edward L. Schwartz, Janice P. Dutcher
Journal: Cancer Research
Cancer Res (1993) 53 (15): 3509–3512.
Published: 01 August 1993
View article titled, Phase I Trial of Cyclophosphamide, Doxorubicin, and 5-Fluorouracil plus Interferon-α2b in Patients with Advanced Breast Cancer
Open the PDF for Phase I Trial of Cyclophosphamide, Doxorubicin, and 5-Fluorouracil plus Interferon-α2b in Patients with Advanced Breast Cancer in another window
Journal Articles

Interaction of Fluorouracil and Interferon in Human Colon Cancer Cell Lines: Cytotoxic and Cytokinetic Effects

Scott Wadler, Robert Wersto, Vivian Weinberg, Deborah Thompson, Edward L. Schwartz
Journal: Cancer Research
Cancer Res (1990) 50 (18): 5735–5739.
Published: 01 September 1990
View article titled, Interaction of Fluorouracil and Interferon in Human Colon Cancer Cell Lines: Cytotoxic and Cytokinetic Effects
Open the PDF for Interaction of Fluorouracil and Interferon in Human Colon Cancer Cell Lines: Cytotoxic and Cytokinetic Effects in another window
Journal Articles

Antineoplastic Activity of the Combination of Interferon and Cytotoxic Agents against Experimental and Human Malignancies: A Review

Scott Wadler, Edward L. Schwartz
Journal: Cancer Research
Cancer Res (1990) 50 (12): 3473–3486.
Published: 01 June 1990
View article titled, Antineoplastic Activity of the Combination of Interferon and Cytotoxic Agents against Experimental and Human Malignancies: A Review
Open the PDF for Antineoplastic Activity of the Combination of Interferon and Cytotoxic Agents against Experimental and Human Malignancies: A Review in another window
Journal Articles

Phase I Trial of 5-Fluorouracil and Recombinant α2a-Interferon in Patients with Advanced Colorectal Carcinoma

Scott Wadler, Mark Goldman, Anne Lyver, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (1990) 50 (7): 2056–2059.
Published: 01 April 1990
View article titled, Phase I Trial of 5-Fluorouracil and Recombinant α<sub>2a</sub>-Interferon in Patients with Advanced Colorectal Carcinoma
Open the PDF for Phase I Trial of 5-Fluorouracil and Recombinant α<sub>2a</sub>-Interferon in Patients with Advanced Colorectal Carcinoma in another window
Journal Articles

Partial Reversal of Doxorubicin Resistance by Forskolin and 1,9-Dideoxyforskolin in Murine Sarcoma S180 Variants

Scott Wadler, Peter H. Wiernik
Journal: Cancer Research
Cancer Res (1988) 48 (3): 539–543.
Published: 01 February 1988
View article titled, Partial Reversal of Doxorubicin Resistance by Forskolin and 1,9-Dideoxyforskolin in Murine Sarcoma S180 Variants
Open the PDF for Partial Reversal of Doxorubicin Resistance by Forskolin and 1,9-Dideoxyforskolin in Murine Sarcoma S180 Variants in another window
Journal Articles

Synergistic Activity of Doxorubicin and the Bisdioxopiperazine (+)-1,2-Bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the Murine Sarcoma S180 Cell Line

Scott Wadler, Michael D. Green, Franco M. Muggia
Journal: Cancer Research
Cancer Res (1986) 46 (3): 1176–1181.
Published: 01 March 1986
View article titled, Synergistic Activity of Doxorubicin and the Bisdioxopiperazine (+)-1,2-Bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the Murine Sarcoma S180 Cell Line
Open the PDF for Synergistic Activity of Doxorubicin and the Bisdioxopiperazine (+)-1,2-Bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the Murine Sarcoma S180 Cell Line in another window